TY  - CONF

T1  - Vascular damaging activity and tumor growth inhibition of ZD6126 in combination with paclitaxel.

JO  - CLINICAL CANCER RESEARCH

PY  - 2005/01/01

AU  - Martinelli M

AU  - Riccardi E

AU  - Zucchetti M

AU  - Ryan A

AU  - Taraboletti G

AU  - Giavazzi R

ED  - 

VL  - 11

IS  - 24

SP  - 8969S

EP  - 8970S

Y2  - 2024/10/23

ER  -